Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect (2014 - 2026)
Amphastar Pharmaceuticals (AMPH) recorded quarterly Exchange Rate Effect of -$138000.0 in Q1 2026, down 1433.33% quarter-over-quarter from -$9000.0 in Q4 2025, and down 216.95% on a YoY basis from $118000.0 in Q1 2025.
Amphastar Pharmaceuticals (AMPH) Exchange Rate Effect (2014 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Exchange Rate Effect history runs 13 years deep, the most recent figure standing at -$138000.0 for Q1 2026.
- In Q1 2026, Exchange Rate Effect fell 216.95% year-over-year to -$138000.0; the TTM figure through Mar 2026 stood at -$46000.0 (down 284.0% YoY), while the FY2025 annual figure was $210000.0, up 210.53% from the prior year.
- Exchange Rate Effect was -$138000.0 for Q1 2026 at Amphastar Pharmaceuticals, down from -$9000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $142000.0 in Q2 2025 to a low of -$238000.0 in Q4 2023.
- Historically, Exchange Rate Effect has averaged -$36470.6 across 5 years, with a median of -$29000.0 in 2022.
- The sharpest annual moves came in 2023 and 2025: Exchange Rate Effect sank 1352.63% in 2023, then jumped 847.37% in 2025.
- A 5-year view of Exchange Rate Effect shows it stood at $19000.0 in 2022, then tumbled by 1352.63% to -$238000.0 in 2023, then soared by 95.38% to -$11000.0 in 2024, then increased by 18.18% to -$9000.0 in 2025, then sank by 1433.33% to -$138000.0 in 2026.
- The last three Exchange Rate Effect figures came in at -$138000.0 (Q1 2026), -$9000.0 (Q4 2025), and -$41000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -17.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 17.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -5.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -2.38 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | -22,000.00 |
| 10 | Amphastar Pharmaceuticals | 914.14 Mn | 914.14 Mn | 70.32 Mn | -138,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -138,000.00 |
| Mar 31, 2026 | -138,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Dec 31, 2025 | -9,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Sep 30, 2025 | -41,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Jun 30, 2025 | 142,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Dec 31, 2024 | -11,000.00 |
| Sep 30, 2024 | -63,000.00 |
| Sep 30, 2024 | -63,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Jun 30, 2024 | -19,000.00 |
| Mar 31, 2024 | -97,000.00 |
| Mar 31, 2024 | -97,000.00 |
| Dec 31, 2023 | -238,000.00 |
| Dec 31, 2023 | -238,000.00 |